Lassa fever epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Changes made per Mahshid's request)
 
(44 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Lassa fever}}
{{Lassa fever}}
{{CMG}}
{{CMG}}; {{AE}} {{Ammu}}
 
{{SK}} Lassa hemorrhagic fever; LHF
==Overview==
==Overview==
Lassa fever is endemic in parts of west Africa including Sierra Leone, Liberia, Guinea and Nigeria; however, other neighboring countries are also at risk, as the animal vector for Lassa virus, the "multimammate rat" (Mastomys natalensis) is distributed throughout the region. Lassa fever causes 100,000-300,000 infections and approximately 5,000 deaths annually.<ref name=CDC>{{cite web | title = The Centers for Disease Control and Prevention facts sheets | url =http://www.cdc.gov/vhf/lassa/pdf/factsheet.pdf }}</ref>
Lassa fever is endemic in West Africa and is rare in developed countries. Lassa virus infects 100,000-300,000 individuals annually with a case fatality rate typically reaching 1-5% but may be as high as 65% during outbreaks.<ref name=CDC>{{cite web | title = The Centers for Disease Control and Prevention facts sheets | url =http://www.cdc.gov/vhf/lassa/pdf/factsheet.pdf }}</ref> There is no predilection to specific age groups, gender, or race. However, young age and pregnancy are associated with increased risk of Lassa fever-associated complications.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence===
The dissemination of the [[infection]] can be assessed by [[prevalence]] of [[antibodies]] to the virus in [[population]]s of:
*Sierra Leone  8&ndash;52%
*Guinea 4&ndash;55%
*Nigeria approx. 21%
[[File:Outbreak Distribution Map Lassa Fever CDC.png|thumb|center|400 px|Outbreak Distribution Map Lassa Fever CDC.png<SMALL><SMALL>''[http://www.cdc.gov/vhf/lassa/outbreaks/index.html]''<ref name="CDC">{{Cite web | title = Center for Disease Control and Prevention (CDC) | url =  http://www.cdc.gov}}</ref></SMALL></SMALL>]]
* A serological survey among patients admitted with a history of fever and missionaries that had experienced a febrile illness showed that LASV was also present in Ivory Coast, Mali, and Central African Republic<ref name="pmid1085213">{{cite journal| author=Frame JD| title=Surveillance of Lassa fever in missionaries stationed in West Africa. | journal=Bull World Health Organ | year= 1975 | volume= 52 | issue= 4-6 | pages= 593-8 | pmid=1085213 | doi= | pmc=PMC2366625 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1085213  }} </ref>.
* The notion that LASV was endemic in larger areas of West Africa was further supported by the results of investigation of an imported case of Lassa fever in Germany in 2000.<ref name="pmid23202452">{{cite journal| author=Yun NE, Walker DH| title=Pathogenesis of Lassa fever. | journal=Viruses | year= 2012 | volume= 4 | issue= 10 | pages= 2031-48 | pmid=23202452 | doi=10.3390/v4102031 | pmc=PMC3497040 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23202452  }} </ref> During the incubation period, the index patient traveled through several countries, namely Ghana, Ivory Coast, and Burkina Faso, that were not considered to be endemic at that time<ref name="pmid10998376">{{cite journal| author=Günther S, Emmerich P, Laue T, Kühle O, Asper M, Jung A et al.| title=Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. | journal=Emerg Infect Dis | year= 2000 | volume= 6 | issue= 5 | pages= 466-76 | pmid=10998376 | doi=10.3201/eid0605.000504 | pmc=PMC2627947 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10998376  }} </ref>.
* Later, cases of Lassa fever have been reported from Burkina Faso, Ivory Coast, Ghana, Senegal, Gambia, and Mali<ref name="pmid17848068">{{cite journal| author=Gonzalez JP, Emonet S, de Lamballerie X, Charrel R| title=Arenaviruses. | journal=Curr Top Microbiol Immunol | year= 2007 | volume= 315 | issue=  | pages= 253-88 | pmid=17848068 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17848068  }} </ref><ref name="pmid20587185">{{cite journal| author=Safronetz D, Lopez JE, Sogoba N, Traore' SF, Raffel SJ, Fischer ER et al.| title=Detection of Lassa virus, Mali. | journal=Emerg Infect Dis | year= 2010 | volume= 16 | issue= 7 | pages= 1123-6 | pmid=20587185 | doi=10.3201/eid1607.100146 | pmc=PMC3321918 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20587185  }} </ref>.
* The high degree of seroprevalence of LASV-specific antibodies in the general population residing in the endemic regions, although highly variable depending on the geographical location (from 1.8% to 55%) [<ref name="pmid3805771">{{cite journal| author=McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES| title=A prospective study of the epidemiology and ecology of Lassa fever. | journal=J Infect Dis | year= 1987 | volume= 155 | issue= 3 | pages= 437-44 | pmid=3805771 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3805771  }} </ref> indicates that most infections are mild or possibly even asymptomatic and do not result in hospitalization. This is also supported by the findings indicating a high incidence of LASV-specific seroconversion, from 5% to 20% of the nonimmune population per year<ref name="pmid3805771">{{cite journal| author=McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES| title=A prospective study of the epidemiology and ecology of Lassa fever. | journal=J Infect Dis | year= 1987 | volume= 155 | issue= 3 | pages= 437-44 | pmid=3805771 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3805771  }} </ref>. Nosocomial outbreaks are associated with higher mortality rates ranging from 36% to 65%<ref name="pmid4745236">{{cite journal| author=Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, Pinneo L et al.| title=A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. | journal=Am J Trop Med Hyg | year= 1973 | volume= 22 | issue= 6 | pages= 773-9 | pmid=4745236 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4745236  }} </ref>.
===Incidence===
===Incidence===
* According to estimations, LASV is responsible for 100,000-300,000 infections and approximately 5,000 deaths annually.  Unfortunately, such estimates are crude, because [[disease surveillance|surveillance]] for cases of the disease is not uniformly performed. In some areas of Sierra Leone and Liberia, it is known that 10%-16% of people admitted to hospitals have Lassa fever, which indicates the serious impact of the disease on the population of this region.  
* Lassa virus infects 100,000-300,000 individuals annually.  However, these figures are inaccurate given that disease surveillance for cases is not routinely performed.
*In areas of high endemicity, up to 10%-15% of hospitalized patients are diagnosed with Lassa fever.
 
===Case Fatality Rates===
* Generally, the overall case-fatality rate is 5-15%.
* The case fatality rate increases among patients hospitalized for severe infection, and during outbreaks, Lassa fever may be associated with case-fatality rates that reach up to 35-65%.<ref name="pmid4745236">{{cite journal| author=Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, Pinneo L et al.| title=A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. | journal=Am J Trop Med Hyg | year= 1973 | volume= 22 | issue= 6 | pages= 773-9 | pmid=4745236 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4745236  }} </ref>
 
===Age===
===Age===
* People of all ages who are exposed to the infection are vulnerable to get infected.
*There is no age preponderance for Lassa virus infection.
*However, fetuses are at high-risk of death following infection with Lassa fever.


===Gender===
===Gender===
* The death rates are particularly high for women in the third trimester of pregnancy, and for fetuses, about 95% of which die in the uterus of infected pregnant mothers.
* There is no gender preponderance for Lassa virus infection.
* Women in the third trimester of [[pregnancy]] are considered high-risk for development of Lassa fever-associated complications and death.
===Seasonal Variation===
===Seasonal Variation===
* Studies conducted prior to the end of hostilities suggested that the highest incidence of LF in Sierra Leone occurs during the dry season (November to April).<ref name="pmid3805771">{{cite journal| author=McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES| title=A prospective study of the epidemiology and ecology of Lassa fever. | journal=J Infect Dis | year= 1987 | volume= 155 | issue= 3 | pages= 437-44 | pmid=3805771 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3805771  }} </ref>
* The highest incidence of Lassa fever occurs during the dry months from November to April.<ref name="pmid3805771">{{cite journal| author=McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES| title=A prospective study of the epidemiology and ecology of Lassa fever. | journal=J Infect Dis | year= 1987 | volume= 155 | issue= 3 | pages= 437-44 | pmid=3805771 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3805771  }} </ref>
===Race===
* There is no races preponderance for Lassa virus infection.
===Developed Countries===
* The following table lists the individuals infected with Lassa fever and were imported and hospitalized in the United States:<ref name=Historical Lassa Fever Reports and 30-year Clinical Update-The Centers for Disease Control and Prevention articles>{{cite web | title = Historical Lassa Fever Reports and 30-year Clinical Update-The Centers for Disease Control and Prevention articles | url =http://wwwnc.cdc.gov/eid/article/12/5/pdfs/05-0052.pdf }}</ref>
{| style="border: 0px; margin: 5px;" width=800px
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''Year of import'''}}
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''Clinical features'''}}
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''From'''}}
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''To'''}}
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1969||style="padding: 5px 5px; background: #EBEBEB;"|[[Fever]], [[malaise]], [[headache]], [[nausea]], [[sore throat]], [[epigastric]]/right upper quadrant tenderness, [[pleural effusion]], facial/[[cervical edema]], [[dysphagia]], [[elevated transaminases]], [[cough]], [[dyspnea]], [[pulmonary infiltrates]], [[epiglottal edema]], [[lethargy]], [[nystagmus]], [[lightheadedness]], [[dizziness]] without [[vertigo]], [[ataxia]], [[alopecia]]||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|New York
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1975||style="padding: 5px 5px; background: #EBEBEB;"|[[Abdominal pain]], [[diarrhea]], [[fever]], [[headache]], [[myalgia]], [[arthralgia]], [[conjunctival injection]], [[lymphadenopathy]], weight loss, [[pleuritic chest pain]], [[pleural effusion]], unilateral [[deafness]]||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|Washington, DC
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1976||style="padding: 5px 5px; background: #EBEBEB;"|[[Abdominal cramps]], [[nausea]], [[vomiting]], [[diarrhea]], [[fatigue]], [[headache]], [[retroorbital pain]], [[neck]]/[[back pain]], [[paresthesias]], right [[ear pain]], [[fever]], [[vertigo]], [[syncope]], [[dysmorphopsias]], [[alopecia]], [[weight loss]], [[ecchymoses]], [[insomnia]], [[depression]], [[hypotension]], left-sided facial weakness, right-sided [[Babinski reflex]], [[Weber test]] lateralized to the left||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|Washington, DC
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1989||style="padding: 5px 5px; background: #EBEBEB;"|Shaking chills, [[fever]], [[sore throat]], [[myalgia]], [[headache]], [[dysphagia]], bloody [[diarrhea]], elevated [[transaminases]], [[hypotension]], [[adult respiratory distress syndrome]], [[death]]||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|Chicago, IL
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 2004||style="padding: 5px 5px; background: #EBEBEB;"|[[Chills]], [[fever]], [[sore throat]], [[diarrhea]], [[back pain]], [[adult respiratory distress syndrome]], [[death]]||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone and Liberia||style="padding: 5px 5px; background: #F2F2F2;"|Trenton, New Jersy
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 2015||style="padding: 5px 5px; background: #EBEBEB;"|[[Fever]], [[sore throat]], [[tiredness]], [[death]]||style="padding: 5px 5px; background: #F2F2F2;"|Liberia||style="padding: 5px 5px; background: #F2F2F2;"|New Jersy
|}
<SMALL>Data from the Center of Disease Control and Prevention, as of May 2015</SMALL>
 
* The following table lists the individuals infected with Lassa fever who were imported and hospitalized in other non-endemic countries except the United States:<ref name=Historical Lassa Fever Reports and 30-year Clinical Update-The Centers for Disease Control and Prevention articles>{{cite web | title = Historical Lassa Fever Reports and 30-year Clinical Update-The Centers for Disease Control and Prevention articles | url =http://wwwnc.cdc.gov/eid/article/12/5/05-0052-ta1 }}</ref>
{| style="border: 0px; margin: 5px;" width=800px
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''Year of import'''}}
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''Occupation'''}}
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''From'''}}
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''To'''}}
| align="center" style="background:#4479BA; padding: 5px 5px;"|{{fontcolor|#FFF|'''Clinical outcome'''}}
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1971||style="padding: 5px 5px; background: #EBEBEB;"|Nurse||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1971||style="padding: 5px 5px; background: #EBEBEB;"|Physician||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1972||style="padding: 5px 5px; background: #EBEBEB;"|Nurse||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
|-


===Race===
| style="padding: 5px 5px; background: #EBEBEB;"| 1974||style="padding: 5px 5px; background: #EBEBEB;"|Physician||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|Germany||style="padding: 5px 5px; background: #EBEBEB;"|Survived
* People of all ages who are exposed to the infection are vulnerable to get infected.
|-
 
| style="padding: 5px 5px; background: #EBEBEB;"| 1975||style="padding: 5px 5px; background: #EBEBEB;"|Physician||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Died
 
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1976||style="padding: 5px 5px; background: #EBEBEB;"|Engineer||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
 
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1980||style="padding: 5px 5px; background: #EBEBEB;"|Aid worker||style="padding: 5px 5px; background: #F2F2F2;"|Upen Volta||style="padding: 5px 5px; background: #F2F2F2;"|Netherlands||style="padding: 5px 5px; background: #EBEBEB;"|Survived
 
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1981||style="padding: 5px 5px; background: #EBEBEB;"|Teacher||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
 
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1982||style="padding: 5px 5px; background: #EBEBEB;"|Diplomat||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
 
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1984||style="padding: 5px 5px; background: #EBEBEB;"|Geologist||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
 
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1985||style="padding: 5px 5px; background: #EBEBEB;"|Nurse||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
 
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1987||style="padding: 5px 5px; background: #EBEBEB;"|Engineer||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone/Liberia||style="padding: 5px 5px; background: #F2F2F2;"|Israel||style="padding: 5px 5px; background: #EBEBEB;"|Survived
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1987||style="padding: 5px 5px; background: #EBEBEB;"|Engineer||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|Japan||style="padding: 5px 5px; background: #EBEBEB;"|Survived
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 1989||style="padding: 5px 5px; background: #EBEBEB;"|Agricultural specialist||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|Canada||style="padding: 5px 5px; background: #EBEBEB;"|Survived
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 2000||style="padding: 5px 5px; background: #EBEBEB;"|Student||style="padding: 5px 5px; background: #F2F2F2;"|Cotê d'Ivoire/Burkina Faso/Ghana||style="padding: 5px 5px; background: #F2F2F2;"|Germany||style="padding: 5px 5px; background: #EBEBEB;"|Died
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 2000||style="padding: 5px 5px; background: #EBEBEB;"|Peace Keeper||style="padding: 5px 5px; background: #F2F2F2;"|CSierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Died
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 2000||style="padding: 5px 5px; background: #EBEBEB;"|Unknown||style="padding: 5px 5px; background: #F2F2F2;"|Nigeria||style="padding: 5px 5px; background: #F2F2F2;"|Germany||style="padding: 5px 5px; background: #EBEBEB;"|Died
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 2000||style="padding: 5px 5px; background: #EBEBEB;"|Physician||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|Netherlands||style="padding: 5px 5px; background: #EBEBEB;"|Died
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 2003||style="padding: 5px 5px; background: #EBEBEB;"|Peace Keeper||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|United Kingdom||style="padding: 5px 5px; background: #EBEBEB;"|Survived
|-
| style="padding: 5px 5px; background: #EBEBEB;"| 2006||style="padding: 5px 5px; background: #EBEBEB;"|-||style="padding: 5px 5px; background: #F2F2F2;"|Sierra Leone||style="padding: 5px 5px; background: #F2F2F2;"|Germany||style="padding: 5px 5px; background: #EBEBEB;"|Survived
|}
<SMALL>Data from the Center of Disease Control and Prevention, as of May 2015</SMALL>


===Developed Countries===
===Developing Countries===
===Developing Countries===
* Since its initial discovery, nosocomial outbreaks of Lassa fever have occurred repeatedly in following countires.
Lassa virus is most prevalent in countries of West and Central Africa:<ref name="pmid: 5046380">{{cite journal| author=Carey DE, Kemp GE, White HA, Pinneo L, Addy RF, Fom AL et al.| title=Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. | journal=Trans R Soc Trop Med Hyg | year= 1972 | volume= 66 | issue= 3 | pages= 402-8 | pmid=: 5046380 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5046380  }} </ref><ref name="pmid1085214">{{cite journal| author=Bowen GS, Tomori O, Wulff H, Casals J, Noonan A, Downs WG| title=Lassa fever in Onitsha, East Central State, Nigeria in 1974. | journal=Bull World Health Organ | year= 1975 | volume= 52 | issue= 4-6 | pages= 599-604 | pmid=1085214 | doi= | pmc=PMC2366632 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1085214  }} </ref><ref name="pmid6390808">{{cite journal| author=Frame JD, Jahrling PB, Yalley-Ogunro JE, Monson MH| title=Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients. | journal=Trans R Soc Trop Med Hyg | year= 1984 | volume= 78 | issue= 5 | pages= 656-60 | pmid=6390808 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6390808  }} </ref>,<ref name="pmid7580496">{{cite journal| author=Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L et al.| title=Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. | journal=BMJ | year= 1995 | volume= 311 | issue= 7009 | pages= 857-9 | pmid=7580496 | doi= | pmc=PMC2550858 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7580496  }} </ref><ref name="pmid9373625">{{cite journal| author=Bajani MD, Tomori O, Rollin PE, Harry TO, Bukbuk ND, Wilson L et al.| title=A survey for antibodies to Lassa virus among health workers in Nigeria. | journal=Trans R Soc Trop Med Hyg | year= 1997 | volume= 91 | issue= 4 | pages= 379-81 | pmid=9373625 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9373625  }} </ref><ref name="pmid15056044">{{cite journal| author=Fisher-Hoch SP, McCormick JB| title=Lassa fever vaccine. | journal=Expert Rev Vaccines | year= 2004 | volume= 3 | issue= 2 | pages= 189-97 | pmid=15056044 | doi=10.1586/14760584.3.4.S189 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15056044  }} </ref><ref name="pmid16355508">{{cite journal| author=Omilabu SA, Badaru SO, Okokhere P, Asogun D, Drosten C, Emmerich P et al.| title=Lassa fever, Nigeria, 2003 and 2004. | journal=Emerg Infect Dis | year= 2005 | volume= 11 | issue= 10 | pages= 1642-4 | pmid=16355508 | doi=10.3201/eid1110.041343 | pmc=PMC3366737 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16355508  }} </ref>
* Sierra Leone: Panguma, Kenema, 1971–83, 1997, Liberia: Zorzor, 1972; Phebe 1972, 1977, 1982; Ganta 1977, 1982 and Nigeria: Jos, 1970, 1993; Onitsha, 1974; Zonkwa, 1975; Vom, 1975–77, Imo, 1989; Lafia, 1993; and Irrua, 2004 [3],[4],[5],[6],[7],[8],[9].  
*Sierra Leone
* In Guinea, some acute but isolated cases were recorded in hospitals [10] and a single rural outbreak was recorded on the Sierra Leone border in 1982–83 [11].
*Guinea
* Between these two areas, namely in Côte d'Ivoire, Ghana, Togo and Benin, no outbreak has ever been recorded, though isolated cases show evidence of viral circulation in that area [12],[13],[14]. Lassa fever therefore appears to have 2 geographically separate endemic areas: the Mano River region (Guinea, Sierra Leone, Liberia) in the West, and Nigeria in the East.
*Nigeria
*  Geographic distribution of patients presenting to the KGH with LASV antigenemia and anti-LASV IgM serpositivity.
*Ivory Coast
[[File:Journal.pntd.0002748.g004.png|thumb|center|400 px|Geographic distribution of patients presenting to Sierra Leone with LASV antigenemia and anti-LASV IgM serpositivity, 2008–12.<SMALL><SMALL>''[http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0002748]''<ref name="Lassa Fever in Post-Conflict Sierra Leone">{{Cite web | title = Lassa Fever in Post-Conflict Sierra Leone| url =  http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0002748}}</ref></SMALL></SMALL>]]
*Mali
 
*Benin
*Central African Republic
*Liberia
*Burkina Faso
*Senegal
*Ghana
*Gambia<br>
The maps below demonstrate the outbreak distribution of Lassa fever:<ref name="pmid17848068">{{cite journal| author=Gonzalez JP, Emonet S, de Lamballerie X, Charrel R| title=Arenaviruses. | journal=Curr Top Microbiol Immunol | year= 2007 | volume= 315 | issue=  | pages= 253-88 | pmid=17848068 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17848068  }} </ref><ref name="pmid20587185">{{cite journal| author=Safronetz D, Lopez JE, Sogoba N, Traore' SF, Raffel SJ, Fischer ER et al.| title=Detection of Lassa virus, Mali. | journal=Emerg Infect Dis | year= 2010 | volume= 16 | issue= 7 | pages= 1123-6 | pmid=20587185 | doi=10.3201/eid1607.100146 | pmc=PMC3321918 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20587185  }} </ref><ref name="pmid10998376">{{cite journal| author=Günther S, Emmerich P, Laue T, Kühle O, Asper M, Jung A et al.| title=Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. | journal=Emerg Infect Dis | year= 2000 | volume= 6 | issue= 5 | pages= 466-76 | pmid=10998376 | doi=10.3201/eid0605.000504 | pmc=PMC2627947 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10998376  }} </ref>
[[File:Outbreak Distribution Map Lassa Fever CDC.png|thumb|400 px|left|Outbreak Distribution Map Lassa Fever<ref name="CDC">{{Cite web | title = Center for Disease Control and Prevention (CDC) | url = http://www.cdc.gov/vhf/lassa/outbreaks/index.html}}</ref>]]<br>
[[File:Journal.pntd.0002748.g004.png|thumb|400 px|left|Geographic distribution of patients presenting to Sierra Leone with LASV antigenemia and anti-LASV IgM serpositivity, 2008–12.<ref name="Lassa Fever in Post-Conflict Sierra Leone">{{Cite web | title = Lassa Fever in Post-Conflict Sierra Leone| url =  http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0002748}}</ref>]]<br>
[[File:Nigeria.jpg|thumb|400 px|left|Map of Nigeria showing States where cases of acute abdomen from Lassa fever were reported.<ref name="Lassa Fever in Post-Conflict Sierra Leone">{{Cite web | title = Lassa fever presenting as acute abdomen: a case series| url =  http://www.virologyj.com/content/10/1/123}}</ref>]]
<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>


==References==
==References==
Line 50: Line 135:
[[Category:Tropical disease]]
[[Category:Tropical disease]]
[[Category:Biological weapons]]
[[Category:Biological weapons]]
[[Category:Infectious disease]]
 
[[Category:Needs content]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 18:08, 18 September 2017

Lassa fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Lassa fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lassa fever epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lassa fever epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lassa fever epidemiology and demographics

CDC on Lassa fever epidemiology and demographics

Lassa fever epidemiology and demographics in the news

Blogs on Lassa fever epidemiology and demographics

Directions to Hospitals Treating Lassa fever

Risk calculators and risk factors for Lassa fever epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Lassa fever is endemic in West Africa and is rare in developed countries. Lassa virus infects 100,000-300,000 individuals annually with a case fatality rate typically reaching 1-5% but may be as high as 65% during outbreaks.[1] There is no predilection to specific age groups, gender, or race. However, young age and pregnancy are associated with increased risk of Lassa fever-associated complications.

Epidemiology and Demographics

Incidence

  • Lassa virus infects 100,000-300,000 individuals annually. However, these figures are inaccurate given that disease surveillance for cases is not routinely performed.
  • In areas of high endemicity, up to 10%-15% of hospitalized patients are diagnosed with Lassa fever.

Case Fatality Rates

  • Generally, the overall case-fatality rate is 5-15%.
  • The case fatality rate increases among patients hospitalized for severe infection, and during outbreaks, Lassa fever may be associated with case-fatality rates that reach up to 35-65%.[2]

Age

  • There is no age preponderance for Lassa virus infection.
  • However, fetuses are at high-risk of death following infection with Lassa fever.

Gender

  • There is no gender preponderance for Lassa virus infection.
  • Women in the third trimester of pregnancy are considered high-risk for development of Lassa fever-associated complications and death.

Seasonal Variation

  • The highest incidence of Lassa fever occurs during the dry months from November to April.[3]

Race

  • There is no races preponderance for Lassa virus infection.

Developed Countries

  • The following table lists the individuals infected with Lassa fever and were imported and hospitalized in the United States:
Year of import Clinical features From To
1969 Fever, malaise, headache, nausea, sore throat, epigastric/right upper quadrant tenderness, pleural effusion, facial/cervical edema, dysphagia, elevated transaminases, cough, dyspnea, pulmonary infiltrates, epiglottal edema, lethargy, nystagmus, lightheadedness, dizziness without vertigo, ataxia, alopecia Nigeria New York
1975 Abdominal pain, diarrhea, fever, headache, myalgia, arthralgia, conjunctival injection, lymphadenopathy, weight loss, pleuritic chest pain, pleural effusion, unilateral deafness Sierra Leone Washington, DC
1976 Abdominal cramps, nausea, vomiting, diarrhea, fatigue, headache, retroorbital pain, neck/back pain, paresthesias, right ear pain, fever, vertigo, syncope, dysmorphopsias, alopecia, weight loss, ecchymoses, insomnia, depression, hypotension, left-sided facial weakness, right-sided Babinski reflex, Weber test lateralized to the left Sierra Leone Washington, DC
1989 Shaking chills, fever, sore throat, myalgia, headache, dysphagia, bloody diarrhea, elevated transaminases, hypotension, adult respiratory distress syndrome, death Nigeria Chicago, IL
2004 Chills, fever, sore throat, diarrhea, back pain, adult respiratory distress syndrome, death Sierra Leone and Liberia Trenton, New Jersy
2015 Fever, sore throat, tiredness, death Liberia New Jersy

Data from the Center of Disease Control and Prevention, as of May 2015

  • The following table lists the individuals infected with Lassa fever who were imported and hospitalized in other non-endemic countries except the United States:
Year of import Occupation From To Clinical outcome
1971 Nurse Sierra Leone United Kingdom Survived
1971 Physician Sierra Leone United Kingdom Survived
1972 Nurse Sierra Leone United Kingdom Survived
1974 Physician Nigeria Germany Survived
1975 Physician Nigeria United Kingdom Died
1976 Engineer Nigeria United Kingdom Survived
1980 Aid worker Upen Volta Netherlands Survived
1981 Teacher Nigeria United Kingdom Survived
1982 Diplomat Nigeria United Kingdom Survived
1984 Geologist Sierra Leone United Kingdom Survived
1985 Nurse Sierra Leone United Kingdom Survived
1987 Engineer Sierra Leone/Liberia Israel Survived
1987 Engineer Sierra Leone Japan Survived
1989 Agricultural specialist Nigeria Canada Survived
2000 Student Cotê d'Ivoire/Burkina Faso/Ghana Germany Died
2000 Peace Keeper CSierra Leone United Kingdom Died
2000 Unknown Nigeria Germany Died
2000 Physician Sierra Leone Netherlands Died
2003 Peace Keeper Sierra Leone United Kingdom Survived
2006 - Sierra Leone Germany Survived

Data from the Center of Disease Control and Prevention, as of May 2015

Developing Countries

Lassa virus is most prevalent in countries of West and Central Africa:[4][5][6],[7][8][9][10]

  • Sierra Leone
  • Guinea
  • Nigeria
  • Ivory Coast
  • Mali
  • Benin
  • Central African Republic
  • Liberia
  • Burkina Faso
  • Senegal
  • Ghana
  • Gambia

The maps below demonstrate the outbreak distribution of Lassa fever:[11][12][13]

Outbreak Distribution Map Lassa Fever[1]


Geographic distribution of patients presenting to Sierra Leone with LASV antigenemia and anti-LASV IgM serpositivity, 2008–12.[14]


Map of Nigeria showing States where cases of acute abdomen from Lassa fever were reported.[14]


























































References

  1. 1.0 1.1 "The Centers for Disease Control and Prevention facts sheets" (PDF).
  2. Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, Pinneo L; et al. (1973). "A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972". Am J Trop Med Hyg. 22 (6): 773–9. PMID 4745236.
  3. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES (1987). "A prospective study of the epidemiology and ecology of Lassa fever". J Infect Dis. 155 (3): 437–44. PMID 3805771.
  4. Carey DE, Kemp GE, White HA, Pinneo L, Addy RF, Fom AL; et al. (1972). "Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria". Trans R Soc Trop Med Hyg. 66 (3): 402–8. PMID 5046380 : 5046380 Check |pmid= value (help).
  5. Bowen GS, Tomori O, Wulff H, Casals J, Noonan A, Downs WG (1975). "Lassa fever in Onitsha, East Central State, Nigeria in 1974". Bull World Health Organ. 52 (4–6): 599–604. PMC 2366632. PMID 1085214.
  6. Frame JD, Jahrling PB, Yalley-Ogunro JE, Monson MH (1984). "Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients". Trans R Soc Trop Med Hyg. 78 (5): 656–60. PMID 6390808.
  7. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L; et al. (1995). "Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice". BMJ. 311 (7009): 857–9. PMC 2550858. PMID 7580496.
  8. Bajani MD, Tomori O, Rollin PE, Harry TO, Bukbuk ND, Wilson L; et al. (1997). "A survey for antibodies to Lassa virus among health workers in Nigeria". Trans R Soc Trop Med Hyg. 91 (4): 379–81. PMID 9373625.
  9. Fisher-Hoch SP, McCormick JB (2004). "Lassa fever vaccine". Expert Rev Vaccines. 3 (2): 189–97. doi:10.1586/14760584.3.4.S189. PMID 15056044.
  10. Omilabu SA, Badaru SO, Okokhere P, Asogun D, Drosten C, Emmerich P; et al. (2005). "Lassa fever, Nigeria, 2003 and 2004". Emerg Infect Dis. 11 (10): 1642–4. doi:10.3201/eid1110.041343. PMC 3366737. PMID 16355508.
  11. Gonzalez JP, Emonet S, de Lamballerie X, Charrel R (2007). "Arenaviruses". Curr Top Microbiol Immunol. 315: 253–88. PMID 17848068.
  12. Safronetz D, Lopez JE, Sogoba N, Traore' SF, Raffel SJ, Fischer ER; et al. (2010). "Detection of Lassa virus, Mali". Emerg Infect Dis. 16 (7): 1123–6. doi:10.3201/eid1607.100146. PMC 3321918. PMID 20587185.
  13. Günther S, Emmerich P, Laue T, Kühle O, Asper M, Jung A; et al. (2000). "Imported lassa fever in Germany: molecular characterization of a new lassa virus strain". Emerg Infect Dis. 6 (5): 466–76. doi:10.3201/eid0605.000504. PMC 2627947. PMID 10998376.
  14. 14.0 14.1 "Lassa Fever in Post-Conflict Sierra Leone".


Template:WikiDoc Sources